Decoding Alzheimer’s Amyloid-Beta Pathology through Astrocytic and Microglial GRNs via Single-Cell AI
CSEF · 2026 Computational Science (Senior Division)
Overview
Alzheimer's disease (AD) affects over 55 million individuals globally, yet fewer than 5% of cases are diagnosed at the mild cognitive impairment stage when therapeutic intervention is most effective, and an estimated 40–60% of synapses are already lost before clinical symptom onset. Conventional differential gene expression (DGE) methods analyze genes in isolation, failing to capture the coordinated regulatory programs driving this early neurodegeneration. To address this gap, I developed a network-informed biomarker discovery framework integrating gene-regulatory connectivity with single-cell expression profiles from the AD Progression Atlas (32 donors; astrocytes and microglia; 5 brain regions; quantitative pTau and Thal amyloid staging). Gene regulatory networks were inferred using ARACNe and integrated with GREmLN to generate regulatory embeddings, upon which region-specific classifiers were trained under strict patient-level cross-validation. Network-informed models achieved a 2-fold improvement in F1 score over DGE-based classifiers (0.69 ± 0.08 vs. 0.35 ± 0.05; p < 0.01), and perturbation-based feature importance identified 5,663 biomarker candidates significantly enriched for synaptic maintenance (adjusted p = 3.2 × 10⁻⁶) and neuroinflammatory pathways (adjusted p = 1.7 × 10⁻⁴), with AGRN and DVL1 emerging as convergent regulators of synaptic-integrity disruption. Independent validation in the SEA-AD cohort (84 donors; middle temporal gyrus) reproduced this advantage, with embedding classifiers outperforming expression-only models by 75% in F1 score (0.42 vs. 0.24). These findings demonstrate that incorporating regulatory network structure into representation learning significantly enhances early-stage AD classification, offering a scalable paradigm for transcriptomic biomarker discovery across complex neurodegenerative diseases.
Competition history
- CSEF 2026
Related projects
ISEF · 2025
Non-Invasive Blood-Based Early Alzheimer's Detection Using Sex-Specific Brain-Blood Graph Reinforcement Learning
CSEF · 2026
NeuroAxisNet: Brain-Blood Network-Guided Transformers Reveal Early Signatures of Alzheimer’s Progression and Resilience
AJAS · 2024
Classifying Alzheimer’s Disease Outcome in Single-Cell RNA-Seq Datasets
ISEF · 2025
Inference of Cell-Cell Communication to Understand the Molecular Mechanisms of Alzheimer's Disease
ISEF · 2024
Alzheimer's Recognition Using Artificial Intelligence
ISEF · 2020
Functional Genetic Biomarkers of Alzheimer's Disease and Gene Expression from Peripheral Blood
ISEF · 2022
Variant Effect Prediction Using Deep Neural Networks for Alzheimer's Disease
ISEF · 2025
Leveraging a Context-Aware Graph Neural Network for Drug Target Discovery in Alzheimer's Disease
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects